December 9, 2025 8:54 am
Key Moments The Magnum Ice Cream Company began trading independently following its demerger from Unilever, closing at €12.84 on December 8, 2025. J.P. Morgan initiated coverage at “neutral” with a December 2027 price target of €14, citing transition cost pressures through 2025 and 2026. Analysts project 6% EPS CAGR from 2025-2029 and see sizable long-term […]
Read moreDecember 9, 2025 7:26 am
Key Moments Nasdaq futures twice failed to break above 25,855, confirming it as a structural resistance level and triggering a 214-point downside rotation. The decline carried price into the confluence of the 6-day rising channel base, the Monthly POC, and projected intraday support near 25,591. As of early Tuesday in the Asian session, the Index […]
Read moreDecember 8, 2025 3:10 pm
Key Moments Paramount launched a hostile $30-per-share all-cash tender offer directly to Warner Bros. Discovery shareholders, including the Global Networks business. Netflix previously agreed to acquire Warner Bros. Discovery for $27.75 per share in a cash-and-stock deal, valuing the company at an enterprise value of $82.7 billion including debt. President Donald Trump said the Netflix-Warner […]
Read moreDecember 8, 2025 2:51 pm
Key Moments IBM agreed to acquire Confluent in an all-cash deal worth $11 billion, or $31 per share. This price represents a premium of about 34% to Confluent’s Friday close. The companies expect the transaction to close by mid-2026, and it remains subject to the usual completion conditions. IBM continues to expand its AI and […]
Read moreDecember 8, 2025 1:32 pm
Key Moments Ascent Solar Technologies, Inc. (NASDAQ:ASTI) entered into a definitive agreement for a $2 million private placement, and investors may generate up to approximately $3.5 million more through warrant exercises. The transaction is priced at-the-market under Nasdaq rules and includes common stock or pre-funded warrants, plus series A and series B warrants with an […]
Read moreDecember 8, 2025 1:07 pm
Key Moments Recursion Pharmaceuticals (NASDAQ:RXRX) shares climbed 7% after reporting positive Phase 2 data for REC-4881 in familial adenomatous polyposis (FAP). REC-4881 led to a 75% response rate among evaluable patients, with a 43% median reduction in total polyp burden at 12 weeks and durable effects after treatment cessation. The company aims to engage with […]
Read moreDecember 8, 2025 12:53 pm
Key Moments Nasdaq, S&P 500, and Dow futures traded slightly higher as all three major indexes sat within 1.6% of their record closing highs. Markets reflected an 87% probability that the Federal Reserve would cut its key policy rate to a 3.5% to 3.75% range this week. Todd Combs will leave Berkshire Hathaway to join […]
Read moreDecember 8, 2025 11:32 am
Key Moments Pegasus Airlines agreed to acquire Smartwings and its owner, Czech Airlines, from Prague City Air in a deal valued at 154 million euros (almost $180 million). The transfer of ownership of Czech Airlines is expected to be finalized within 12 months, according to a Smartwings spokesperson. Smartwings serves around 80 destinations with nearly […]
Read moreDecember 8, 2025 9:36 am
Key Moments TotalEnergies will hold a 47.5% stake in NEO NEXT+, becoming the largest shareholder in the new U.K. oil and gas venture. The merged entity is projected to produce about 250,000 barrels of oil equivalent per day in 2026, pending deal completion. TotalEnergies plans to retain up to $2.3 billion of decommissioning liabilities tied […]
Read moreDecember 8, 2025 9:00 am
Key Moments Morgan Stanley Capital Services LLC reported Avadel Pharmaceuticals plc (NASDAQ:AVDL) share dealings to the Irish Takeover Panel under Rule 38.5(a). The firm bought 5,770 Avadel ordinary shares and sold 87 shares on December 5, 2025, at prices between $21.34 and $21.37 per share. Morgan Stanley also expanded a short position in Avadel via […]
Read more